Dengue Shock Syndrome
📧 Sign up to get email alerts when something new happens for Dengue Shock Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: Efficacy of Fresh Frozen Plasma (FFP) in Treating Thrombocytopenia in Dengue Patients [NA]
This entry provides an update on a clinical trial evaluating the efficacy of fresh frozen plasma for dengue-associated thrombocytopenia; the…
-
CLINICAL_TRIALS trial_result · 2023-07-18Clinical Trial Update: Effect of Montelukast in Preventing Dengue With Warning Signs in Dengue Patients [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluated montelukast for preventing progression in dengue patients with warning signs, with the study completed.
-
CLINICAL_TRIALS trial_result · 2017-06-06Clinical Trial Update: A Study of Two Doses of WRAIR Dengue Vaccine Administered Six Months Apart to Healthy Adults and Children [Phase 2]
Phase 2 study evaluating two doses of the WRAIR Dengue Vaccine given six months apart in healthy adults and children completed. Results were…
-
CLINICAL_TRIALS trial_result · 2013-01-03Clinical Trial Update: Safety of and Immune Response to DEN4 Vaccine Component Candidate for Dengue Virus [Phase 1]
Phase 1 clinical trial evaluating safety and immune response to a DEN4 dengue vaccine component candidate; the study has been completed.
-
CLINICAL_TRIALS research · 2009-08-28Clinical Trial Update: Effect of Hypertonic Sodium Lactate on sVCAM-1 Level as Surrogate Marker of Endothelial Capillary Leakage in Pediatric Dengue Shock Syndrome Patients (DSS) [Phase 3]
Phase 3 trial evaluating hypertonic sodium lactate on a surrogate marker of endothelial leakage in pediatric dengue shock syndrome. Current …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.